• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在CATIE样本中针对抗精神病药物所致体重增加的全基因组关联研究。

Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.

作者信息

Brandl E J, Tiwari A K, Zai C C, Nurmi E L, Chowdhury N I, Arenovich T, Sanches M, Goncalves V F, Shen J J, Lieberman J A, Meltzer H Y, Kennedy J L, Müller D J

机构信息

Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Berlin, Germany.

出版信息

Pharmacogenomics J. 2016 Aug;16(4):352-6. doi: 10.1038/tpj.2015.59. Epub 2015 Sep 1.

DOI:10.1038/tpj.2015.59
PMID:26323598
Abstract

Antipsychotic-induced weight gain (AIWG) is a common side effect with a high genetic contribution. We reanalyzed genome-wide association study (GWAS) data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) selecting a refined subset of patients most suitable for AIWG studies. The final GWAS was conducted in N=189 individuals. The top polymorphisms were analyzed in a second cohort of N=86 patients. None of the single-nucleotide polymorphisms was significant at the genome-wide threshold of 5x10(-8). We observed interesting trends for rs9346455 (P=6.49x10(-6)) upstream of OGFRL1, the intergenic variants rs7336345 (P=1.31 × 10(-5)) and rs1012650 (P=1.47 × 10(-5)), and rs1059778 (P=1.49x10(-5)) in IBA57. In the second cohort, rs9346455 showed significant association with AIWG (P=0.005). The combined meta-analysis P-value for rs9346455 was 1.09 × 10(-7). Our reanalysis of the CATIE GWAS data revealed interesting new variants associated with AIWG. As the functional relevance of these polymorphisms is yet to be determined, further studies are needed.The Pharmacogenomics Journal advance online publication, 1 September 2015; doi:10.1038/tpj.2015.59.

摘要

抗精神病药物所致体重增加(AIWG)是一种常见的副作用,且具有较高的遗传因素。我们重新分析了干预有效性临床抗精神病药物试验(CATIE)的全基因组关联研究(GWAS)数据,选择了最适合AIWG研究的患者精细子集。最终的GWAS在N = 189名个体中进行。在另一组N = 86名患者中对顶级多态性进行了分析。在全基因组阈值5×10⁻⁸下,没有单核苷酸多态性是显著的。我们观察到OGFRL1上游的rs9346455(P = 6.49×10⁻⁶)、基因间变体rs7336345(P = 1.31×10⁻⁵)和rs1012650(P = 1.47×10⁻⁵)以及IBA57中的rs1059778(P = 1.49×10⁻⁵)呈现出有趣的趋势。在第二个队列中,rs9346455与AIWG显示出显著关联(P = 0.005)。rs9346455的合并荟萃分析P值为1.09×10⁻⁷。我们对CATIE GWAS数据的重新分析揭示了与AIWG相关的有趣新变体。由于这些多态性的功能相关性尚未确定,因此需要进一步研究。《药物基因组学杂志》在线优先发表,2015年9月1日;doi:10.1038/tpj.2015.59 。

相似文献

1
Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.在CATIE样本中针对抗精神病药物所致体重增加的全基因组关联研究。
Pharmacogenomics J. 2016 Aug;16(4):352-6. doi: 10.1038/tpj.2015.59. Epub 2015 Sep 1.
2
Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.全基因组关联研究表明,PTPRD基因多态性与非典型抗精神病药物的体重增加效应有关。
Schizophr Bull. 2016 May;42(3):814-23. doi: 10.1093/schbul/sbv179. Epub 2015 Dec 9.
3
Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis.瘦素基因-2548G/A 多态性与抗精神病药引起的体重增加的关联:CATIE 样本分析及荟萃分析。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Aug 30;102:109952. doi: 10.1016/j.pnpbp.2020.109952. Epub 2020 Apr 23.
4
Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation.全基因组关联研究提示脂质代谢通路功能障碍与抗精神病药引起的体重增加有关:多祖验证。
Mol Psychiatry. 2024 Jun;29(6):1857-1868. doi: 10.1038/s41380-024-02447-2. Epub 2024 Feb 9.
5
Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain.分子通路分析将肥胖相关基因的改变与抗精神病药引起的体重增加联系起来。
Acta Neuropsychiatr. 2020 Apr;32(2):72-83. doi: 10.1017/neu.2019.41. Epub 2019 Nov 14.
6
A comprehensive analysis of mitochondrial genes variants and their association with antipsychotic-induced weight gain.线粒体基因变异及其与抗精神病药物所致体重增加的关联的综合分析。
Schizophr Res. 2017 Sep;187:67-73. doi: 10.1016/j.schres.2017.06.046. Epub 2017 Jul 8.
7
A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.一项关于28个核编码线粒体基因与精神分裂症中抗精神病药物所致体重增加的假设驱动关联研究。
Neuropsychopharmacology. 2014 May;39(6):1347-54. doi: 10.1038/npp.2013.312. Epub 2013 Nov 7.
8
Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans.全基因组关联研究抗精神病药引起的欧洲裔和非裔美国人的体重增加。
Schizophr Res. 2019 Oct;212:204-212. doi: 10.1016/j.schres.2019.07.022. Epub 2019 Aug 22.
9
Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.瘦素和瘦素受体基因多态性与抗精神病药引起的体重增加的相关性研究。
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):134-41. doi: 10.1016/j.pnpbp.2012.03.001. Epub 2012 Mar 8.
10
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.GRM7基因、对利培酮的早期反应与精神分裂症:一项全基因组关联研究及验证性药物遗传学分析
Pharmacogenomics J. 2017 Mar;17(2):146-154. doi: 10.1038/tpj.2015.90. Epub 2016 Feb 9.

引用本文的文献

1
Pharmacogenetic study of antipsychotic-induced lipid and BMI changes in Chinese schizophrenia patients: A Genome-Wide Association Study.中国精神分裂症患者抗精神病药物引起的脂质和体重指数变化的药物遗传学研究:一项全基因组关联研究
Transl Psychiatry. 2025 Aug 19;15(1):295. doi: 10.1038/s41398-025-03499-w.
2
Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments.用于抗精神病药物治疗个体化的药物基因组学的临床效用与实施
Pharmaceutics. 2024 Feb 7;16(2):244. doi: 10.3390/pharmaceutics16020244.
3
Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis.

本文引用的文献

1
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed.抗精神病药物所致体重增加:遗传学、表观遗传学及生物标志物综述
Curr Psychiatry Rep. 2014 Oct;16(10):473. doi: 10.1007/s11920-014-0473-9.
2
Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain.胰高血糖素基因(GCG)和胰高血糖素样肽-1受体基因(GLP1R)的遗传变异与抗精神病药物所致体重增加
Pharmacogenomics. 2014 Mar;15(4):423-31. doi: 10.2217/pgs.13.247.
3
A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
在一项瑞士精神科纵向研究中,通过全基因组关联分析鉴定出与精神药物引起的体重增加相关的四个新位点。
Mol Psychiatry. 2023 Jun;28(6):2320-2327. doi: 10.1038/s41380-023-02082-3. Epub 2023 May 12.
4
CYP2D6 Genetic Variation and Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis.CYP2D6基因变异与抗精神病药物所致体重增加:一项系统评价与荟萃分析。
Front Psychol. 2022 Feb 3;12:768748. doi: 10.3389/fpsyg.2021.768748. eCollection 2021.
5
Identification of as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data.基于多组织基因表达数据的综合生物信息学分析,鉴定某基因作为抗精神病药物诱导的代谢失调中的关键基因。 (原文中“Identification of as a Key Gene”部分缺失具体基因名称)
Front Pharmacol. 2021 Aug 13;12:729474. doi: 10.3389/fphar.2021.729474. eCollection 2021.
6
Association of CNR1 and INSIG2 polymorphisms with antipsychotics-induced weight gain: a prospective nested case-control study.CNR1 和 INSIG2 多态性与抗精神病药引起的体重增加的关联:一项前瞻性巢式病例对照研究。
Sci Rep. 2021 Jul 27;11(1):15304. doi: 10.1038/s41598-021-94700-9.
7
Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder.精神分裂症、双相情感障碍和重度抑郁症中与药物反应相关的DNA甲基化变化
Front Neurosci. 2021 May 13;15:674273. doi: 10.3389/fnins.2021.674273. eCollection 2021.
8
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children.儿童抗精神病药物所致体重增加及代谢综合征的负担
Front Psychiatry. 2021 Mar 12;12:623681. doi: 10.3389/fpsyt.2021.623681. eCollection 2021.
9
Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications.抗精神病药物治疗的药物遗传学:更新与临床意义
Mol Neuropsychiatry. 2020 Apr;5(Suppl 1):1-26. doi: 10.1159/000492332. Epub 2018 Sep 26.
10
A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort).抗精神病药物所致体重增加的一个新基因位点:使用氨磺必利(来自OPTiMiSE队列)对首发精神病患者进行的全基因组研究。
J Psychopharmacol. 2020 May;34(5):524-531. doi: 10.1177/0269881120907972. Epub 2020 Mar 4.
一项关于28个核编码线粒体基因与精神分裂症中抗精神病药物所致体重增加的假设驱动关联研究。
Neuropsychopharmacology. 2014 May;39(6):1347-54. doi: 10.1038/npp.2013.312. Epub 2013 Nov 7.
4
MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?MC4R rs489693:第二代抗精神病药相关体重增加的临床风险因素?
Int J Neuropsychopharmacol. 2013 Oct;16(9):2103-9. doi: 10.1017/S1461145713000849. Epub 2013 Aug 7.
5
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.在 RUPP 自闭症网络利培酮研究中,通过能量平衡基因变异来调节抗精神病药引起的体重增加。
Transl Psychiatry. 2013 Jun 25;3(6):e274. doi: 10.1038/tp.2013.26.
6
Mutation of the iron-sulfur cluster assembly gene IBA57 causes severe myopathy and encephalopathy.铁硫簇装配基因 IBA57 的突变导致严重的肌病和脑病。
Hum Mol Genet. 2013 Jul 1;22(13):2590-602. doi: 10.1093/hmg/ddt107. Epub 2013 Mar 5.
7
Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.神经肽 Y 功能多态性与精神分裂症患者抗精神病药引起的体重增加相关。
J Clin Psychopharmacol. 2013 Feb;33(1):11-7. doi: 10.1097/JCP.0b013e31827d145a.
8
Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain.5-羟色胺(2C)受体基因变异在抗精神病药物所致体重增加中的作用
Pharmgenomics Pers Med. 2011;4:83-93. doi: 10.2147/PGPM.S11866. Epub 2011 Aug 18.
9
Pharmacogenomics in clinical practice and drug development.临床实践和药物开发中的药物基因组学。
Nat Biotechnol. 2012 Nov;30(11):1117-24. doi: 10.1038/nbt.2424. Epub 2012 Nov 8.
10
Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.第二代抗精神病药物在精神分裂症中的应用及相关体重增加:行为和药物治疗的批判性综述与荟萃分析
Ann Clin Psychiatry. 2012 Aug;24(3):225-39.